Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Setanaxib |
| Trade Name | |
| Synonyms | GKT137831 |
| Drug Descriptions |
Setanaxib (GKT137831) inhibits NADPH oxidase isoform 1 (NOX1) and isoform 4 (NOX4) (PMID: 20942471), and may potentially alter reactive oxygen species levels and decrease tumor cell growth (PMID: 35326163). |
| DrugClasses | |
| CAS Registry Number | 1218942-37-0 |
| NCIT ID | C166721 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Pembrolizumab + Setanaxib | Pembrolizumab Setanaxib | 0 | 1 |
| Setanaxib | Setanaxib | 0 | 0 |